This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Carl Petersson: Innovator in Disubstituted Alkyne Derivatives
Introduction
Carl Petersson is a notable inventor based in Nykvarn, Sweden. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on disubstituted alkyne derivatives. His research focuses on compounds that hold promise for the prevention and treatment of various medical conditions, including hyperproliferative disorders and diseases.
Latest Patents
Carl Petersson holds 1 patent for his invention related to disubstituted alkyne derivatives. This patent outlines the utility of these compounds in addressing critical health issues, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Carl has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Ryvu Therapeutics S.A. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.
Collaborations
Carl has had the opportunity to work alongside talented individuals such as Andrzej Gondela and Michal Galezowski. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Carl Petersson's work on disubstituted alkyne derivatives exemplifies the innovative spirit of modern inventors. His contributions to medicinal chemistry are paving the way for new treatments and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile